Livzon Group Subsidiary Obtains Drug Registration Certificate for Banxia Baizhu Tianma Decoction Granules

Regulation
โดย 证券时报·Read original
Summary · why it matters

Livzon Group announced that its subsidiary Sichuan Guangda Pharmaceutical Co., Ltd. has received the Drug Registration Certificate for Banxia Baizhu Tianma Decoction Granules issued by the National Medical Products Administration. The drug registration application has been approved, but the specific indications and market impact have not been disclosed in detail in the announcement. Livzon Group stated that this approval will enrich the company's product line, but did not reveal the expected launch time or sales forecast.

Impact on stocks 1

Others▲ · 1 stocks

Off-coverage companies 1

四川光大制药有限公司Private▲ Positive
Regulationrelevance

Received drug registration certificate for Banxia Baizhu Tianma Decoction Granules from NMPA.

© 2026 MarketDXNews